{"id":8048,"date":"2026-06-25T09:44:52","date_gmt":"2026-06-25T01:44:52","guid":{"rendered":"https:\/\/witology.com.tw\/daily-biohealth\/2026-06-25\/"},"modified":"2026-06-25T09:44:52","modified_gmt":"2026-06-25T01:44:52","slug":"9-81","status":"publish","type":"page","link":"https:\/\/witology.com.tw\/en\/daily-biohealth\/9-81\/","title":{"rendered":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-06-25\uff5c\u80a5\u80d6\u75c7\u5927\u8ced\u6ce8\u8207\u4e2d\u570b\u5d1b\u8d77\u63a8\u52d52032\u5e74\u5168\u7403\u85e5\u54c1\u92b7\u552e\u984d\u6709"},"content":{"rendered":"\n<style>.wit-daily {\n  --bg:#0f0e0c;--bg2:#16140f;--fg:#e8e3d8;--dim:#8a8276;--mute:#5a5448;\n  --card:#1a1816;--card2:#221f1b;--bdr:#3a342e;--bdr2:#4a423a;\n  --acc:#c4b09a;--acc2:#d4a574;--acc3:#7a6e62;\n  --tw:#e07a6a;--us:#7ab3d4;\n  --up:#8fc78a;--dn:#d97070;--nu:#9a9282;\n  --warn:#d4a574;\n  --line-h:1.85;\n}\n.wit-daily * {margin:0;padding:0;box-sizing:border-box}\n.wit-daily {background:var(--bg)}\n.wit-daily {font-family:\"Noto Sans TC\",sans-serif;background:var(--bg);color:var(--fg);line-height:var(--line-h);-webkit-font-smoothing:antialiased;background-image:radial-gradient(ellipse 80% 40% at 50% 0%,rgba(196,176,154,.06),transparent 70%)}\n.wit-daily .wrap {max-width:860px;margin:0 auto;padding:40px 22px 80px}\n.wit-daily .hdr {text-align:center;padding:64px 0 48px;margin-bottom:48px;border-bottom:1px solid var(--bdr)}\n.wit-daily .hdr-date {font-size:12px;letter-spacing:8px;color:var(--acc);text-transform:uppercase;margin-bottom:14px;font-weight:500}\n.wit-daily .hdr h1 {font-family:\"Noto Serif TC\",serif;font-size:clamp(30px,5vw,46px);font-weight:700;letter-spacing:3px;margin-bottom:12px;background:linear-gradient(135deg,var(--fg) 0%,var(--acc) 100%);-webkit-background-clip:text;-webkit-text-fill-color:transparent;background-clip:text}\n.wit-daily .hdr-sub {font-size:13px;color:var(--dim);letter-spacing:1px}\n.wit-daily .stats {margin-bottom:48px}\n.wit-daily .st {display:flex;align-items:center;gap:12px;margin-bottom:8px}\n.wit-daily .st-bar {height:3px;border-radius:2px;min-width:3px;transition:width .5s;opacity:.85}\n.wit-daily .st-lb {font-size:13px;flex:1;color:var(--fg)}\n.wit-daily .st-ct {font-size:12px;color:var(--dim);min-width:24px;text-align:right;font-variant-numeric:tabular-nums}\n.wit-daily .lbl {font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;color:var(--fg);margin-bottom:28px;padding-bottom:12px;border-bottom:2px solid var(--acc);letter-spacing:1px}\n.wit-daily .c {background:var(--card);border:1px solid var(--bdr);border-radius:4px;margin-bottom:36px;overflow:hidden;box-shadow:0 4px 24px rgba(0,0,0,.35),0 1px 0 rgba(196,176,154,.05) inset;backdrop-filter:blur(16px)}\n.wit-daily .c-hd {display:flex;justify-content:space-between;align-items:center;padding:22px 30px 0}\n.wit-daily .c-cat {font-size:10px;font-weight:700;letter-spacing:3px;text-transform:uppercase;color:var(--cc,var(--acc));border:1px solid var(--cc,var(--acc));padding:3px 12px;border-radius:2px;background:rgba(0,0,0,.2)}\n.wit-daily .c-snt {font-size:13px;font-weight:600;letter-spacing:.5px}\n.wit-daily .s-up {color:var(--up)}\n.wit-daily .s-dn {color:var(--dn)}\n.wit-daily .s-nu {color:var(--nu)}\n.wit-daily .c-t {padding:14px 30px 4px;font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;line-height:1.45;letter-spacing:.5px}\n.wit-daily .c-t a {color:var(--fg);text-decoration:none;transition:color .25s}\n.wit-daily .c-t a:hover {color:var(--acc2)}\n.wit-daily .c-src {padding:0 30px 14px;font-size:12px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .c-hype {display:flex;align-items:center;gap:14px;padding:10px 30px 14px;border-top:1px dashed var(--bdr);border-bottom:1px dashed var(--bdr);background:rgba(196,176,154,.03)}\n.wit-daily .c-hype-lb {font-size:10px;letter-spacing:2px;text-transform:uppercase;color:var(--dim);font-weight:700}\n.wit-daily .c-hype-dots {font-size:14px;color:var(--acc2);letter-spacing:3px;font-family:monospace}\n.wit-daily .c-hype-tx {font-size:12px;color:var(--acc);font-weight:500}\n.wit-daily .c-stocks {padding:14px 30px 18px;display:flex;flex-wrap:wrap;gap:6px}\n.wit-daily .stk {display:inline-flex;align-items:center;gap:4px;font-size:12px;padding:4px 12px;border-radius:2px;font-weight:500}\n.wit-daily .stk b {font-weight:700}\n.wit-daily .stk-tw {background:rgba(224,122,106,.12);color:var(--tw);border:1px solid rgba(224,122,106,.35)}\n.wit-daily .stk-us {background:rgba(122,179,212,.12);color:var(--us);border:1px solid rgba(122,179,212,.35)}\n.wit-daily .stk-other {background:rgba(255,255,255,.04);color:var(--dim);border:1px solid var(--bdr2)}\n.wit-daily .chg {font-size:11px;font-weight:600;padding:1px 6px;border-radius:2px;margin-left:2px}\n.wit-daily .chg-up {background:rgba(226,100,80,.20);color:#ff8f78}\n.wit-daily .chg-down {background:rgba(94,181,141,.20);color:#7ed0a6}\n.wit-daily .chg-flat {background:rgba(255,255,255,.06);color:var(--dim)}\n.wit-daily .c-img {width:100%;height:auto;aspect-ratio:1170\/540;object-fit:cover;border-top:1px solid var(--bdr);border-bottom:1px solid var(--bdr);filter:brightness(.92);display:block}\n.wit-daily .c-analysis {display:grid;grid-template-columns:1fr 1fr;border-top:1px solid var(--bdr)}\n.wit-daily .c-sec {padding:22px 30px;border-bottom:1px solid var(--bdr)}\n.wit-daily .c-sec:nth-child(odd) {border-right:1px solid var(--bdr)}\n.wit-daily .c-wide {grid-column:1\/-1;border-right:none !important}\n.wit-daily .c-sec h4 {font-size:14px;letter-spacing:2px;text-transform:uppercase;color:var(--acc);margin-bottom:12px;font-weight:700}\n.wit-daily .c-sec p {font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92}\n.wit-daily .c-counter {background:rgba(212,165,116,.05)}\n.wit-daily .c-counter h4 {color:var(--warn)}\n.wit-daily .c-counter blockquote {border-left:3px solid var(--warn);padding:6px 0 6px 16px;font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92;font-style:italic;margin:0}\n.wit-daily .c-watch {background:rgba(196,176,154,.04)}\n.wit-daily .c-watch-grid {display:grid;grid-template-columns:1fr 1fr 1fr;gap:18px;margin-top:6px}\n.wit-daily .c-watch-col {}\n.wit-daily .c-watch-h {font-size:12px;font-weight:700;color:var(--fg);margin-bottom:10px;padding-bottom:6px;border-bottom:1px solid var(--bdr2);display:flex;flex-direction:column;gap:2px}\n.wit-daily .c-watch-h span {font-size:10px;color:var(--dim);letter-spacing:1px;font-weight:400}\n.wit-daily .c-w-short {border-bottom-color:var(--dn)}\n.wit-daily .c-w-mid {border-bottom-color:var(--acc2)}\n.wit-daily .c-w-long {border-bottom-color:var(--up)}\n.wit-daily .c-watch-col ul {list-style:none;padding:0;margin:0}\n.wit-daily .c-watch-col li {font-size:13px;line-height:1.7;color:var(--fg);opacity:.88;padding:6px 0 6px 16px;position:relative}\n.wit-daily .c-watch-col li:before {content:\"\u25b8\";position:absolute;left:0;color:var(--acc);font-size:12px}\n.wit-daily .c-faqs {background:rgba(122,179,212,.04)}\n.wit-daily .c-faqs h4 {color:var(--us)}\n.wit-daily .c-faq-item {border-bottom:1px solid var(--bdr);padding:10px 0}\n.wit-daily .c-faq-item:last-child {border-bottom:none}\n.wit-daily .c-faq-item summary {cursor:pointer;font-size:14px;font-weight:600;color:var(--fg);padding:6px 0;list-style:none;display:flex;align-items:center;gap:10px;transition:color .2s}\n.wit-daily .c-faq-item summary::before {content:\"+\";color:var(--us);font-weight:700;font-size:18px;width:14px;display:inline-block;transition:transform .2s}\n.wit-daily .c-faq-item[open] summary::before {content:\"\u2212\"}\n.wit-daily .c-faq-item summary:hover {color:var(--acc2)}\n.wit-daily .c-faq-item p {font-size:13px;line-height:1.8;color:var(--fg);opacity:.85;padding:8px 0 6px 24px;margin:0}\n.wit-daily .c-ft {padding:16px 30px;border-top:1px solid var(--bdr);text-align:right;background:rgba(0,0,0,.15)}\n.wit-daily .c-ft a {font-size:13px;color:var(--acc);text-decoration:none;font-weight:500;transition:color .25s;letter-spacing:.5px}\n.wit-daily .c-ft a:hover {color:var(--acc2)}\n.wit-daily .briefs {background:var(--card);border:1px solid var(--bdr);border-radius:4px;padding:8px 0;margin-bottom:48px;box-shadow:0 2px 12px rgba(0,0,0,.25)}\n.wit-daily .b-item {display:flex;gap:12px;padding:12px 26px;border-bottom:1px solid var(--bdr);align-items:flex-start}\n.wit-daily .b-item:last-child {border-bottom:none}\n.wit-daily .b-dot {width:7px;height:7px;border-radius:50%;margin-top:9px;flex-shrink:0;box-shadow:0 0 8px currentColor}\n.wit-daily .b-link {color:var(--fg);text-decoration:none;font-size:14px;transition:color .25s;display:block;margin-bottom:2px;line-height:1.6}\n.wit-daily .b-link:hover {color:var(--acc2)}\n.wit-daily .b-meta {font-size:11px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .ftr {text-align:center;padding:36px 0;font-size:11px;color:var(--mute);border-top:1px solid var(--bdr);margin-top:24px;letter-spacing:1px}\n@media(max-width:680px) {.wit-daily .c-analysis {grid-template-columns:1fr}\n.wit-daily .c-sec:nth-child(odd) {border-right:none}\n.wit-daily .c-wide {grid-column:1}\n.wit-daily .c-t {font-size:19px;padding:12px 20px 4px}\n.wit-daily .c-hd, .wit-daily .c-src, .wit-daily .c-stocks, .wit-daily .c-sec, .wit-daily .c-ft, .wit-daily .c-hype {padding-left:20px;padding-right:20px}\n.wit-daily .c-watch-grid {grid-template-columns:1fr;gap:14px}}\n\/* \u5168\u57df(\u975e scoped):\u50c5\u8a72\u7522\u696d\u65e5\u5831\u5b50\u9801\u751f\u6548 *\/\nbody.parent-pageid-7356 .fusion-page-title-bar,\nbody.parent-pageid-7356 .fusion-page-title-row,\nbody.parent-pageid-7356 .fusion-page-title-wrapper {\n  display: none !important;\n  height: 0 !important;\n  padding: 0 !important;\n  margin: 0 !important;\n}\nbody.parent-pageid-7356 #main,\nbody.parent-pageid-7356 #content,\nbody.parent-pageid-7356 .fusion-row,\nbody.parent-pageid-7356 .post-content,\nbody.parent-pageid-7356 article.post {\n  padding-top: 0 !important;\n  margin-top: 0 !important;\n}\n\n\/* scoped(.wit-daily) *\/\n.wit-daily {\n  margin-left: calc((100% - 100vw) \/ 2);\n  margin-right: calc((100% - 100vw) \/ 2);\n  padding-left: calc((100vw - 100%) \/ 2);\n  padding-right: calc((100vw - 100%) \/ 2);\n  padding-top: 40px;\n  padding-bottom: 60px;\n  background: #0f0e0c;\n  color: #e8e3d8;\n  font-family: \"Noto Sans TC\", sans-serif;\n}\n.wit-daily .wrap { padding-left: 22px; padding-right: 22px; padding-top: 0; }\n.wit-daily a { color: inherit; }\n\/* \u5f37\u5236\u8986\u84cb Avada \u4e3b\u984c\u53ef\u80fd\u6ce8\u5165\u7684 blockquote \u767d\u5e95 *\/\n.wit-daily .c-counter blockquote,\n.wit-daily blockquote {\n  background: transparent !important;\n  background-color: transparent !important;\n  color: #e8e3d8 !important;\n  border-left: 3px solid #d4a574 !important;\n  padding: 6px 0 6px 16px !important;\n  font-style: italic !important;\n  margin: 0 !important;\n  box-shadow: none !important;\n}\n.wit-daily .c-counter blockquote::before,\n.wit-daily blockquote::before,\n.wit-daily blockquote::after { content: none !important; }\n<\/style>\n<div class=\"wit-daily\">\n\n<main class=\"wrap\">\n<header class=\"hdr\">\n<div class=\"hdr-date\"><time datetime=\"2026-06-25\">2026 \u5e74 06 \u6708 25 \u65e5<\/time><\/div>\n<h1>\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831<\/h1>\n<p class=\"hdr-sub\">\u5171\u6536\u9304 8 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 2 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/p>\n<\/header>\n<section aria-labelledby=\"sec-featured\">\n<h2 class=\"lbl\" id=\"sec-featured\">\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/h2>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/pharma\/big-obesity-bets-and-chinas-rise-fuel-potential-2t-2032-drug-sales-evaluate\" rel=\"noopener nofollow\" target=\"_blank\">\u80a5\u80d6\u75c7\u5927\u8ced\u6ce8\u8207\u4e2d\u570b\u5d1b\u8d77\u63a8\u52d52032\u5e74\u5168\u7403\u85e5\u54c1\u92b7\u552e\u984d\u6709\u671b\u90542\u5146\u7f8e\u5143\uff1aEvaluate\u5831\u544a<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-06-25\" itemprop=\"datePublished\">2026-06-25<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cf\u25cb<\/span><span class=\"c-hype-tx\">4\/5 \u00b7 \u91cd\u5927\u8a0a\u865f<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>NVO<\/b> Novo Nordisk <span class=\"chg chg-down\">\u25bc0.02% $47.41<\/span><\/span><span class=\"stk stk-us\"><b>LLY<\/b> Eli Lilly <span class=\"chg chg-up\">\u25b20.92% $1117.26<\/span><\/span><span class=\"stk stk-us\"><b>AZN<\/b> AstraZeneca <span class=\"chg chg-up\">\u25b21.10% $183.02<\/span><\/span><span class=\"stk stk-us\"><b>PFE<\/b> Pfizer <span class=\"chg chg-down\">\u25bc2.75% $24.04<\/span><\/span><span class=\"stk stk-other\"><b>ROG<\/b> Roche <span class=\"chg chg-up\">\u25b21.89% $162.14<\/span><\/span><span class=\"stk stk-other\"><b>1177<\/b> \u4e2d\u570b\u751f\u7269\u88fd\u85e5 <span class=\"chg chg-down\">\u25bc0.23% $4.41<\/span><\/span><span class=\"stk stk-other\"><b>1801<\/b> \u4fe1\u9054\u751f\u7269 <span class=\"chg chg-up\">\u25b21.90% $77.95<\/span><\/span><span class=\"stk stk-tw\"><b>6446<\/b> \u85e5\u83ef\u85e5 <span class=\"chg chg-up\">\u25b20.86% $1170.0<\/span><\/span><span class=\"stk stk-tw\"><b>4162<\/b> \u667a\u64ce\u751f\u6280 <span class=\"chg chg-flat\">\u2014<\/span><\/span><\/div>\n<img decoding=\"async\" alt=\"\u80a5\u80d6\u75c7\u5927\u8ced\u6ce8\u8207\u4e2d\u570b\u5d1b\u8d77\u63a8\u52d52032\u5e74\u5168\u7403\u85e5\u54c1\u92b7\u552e\u984d\u6709\u671b\u90542\u5146\u7f8e\u5143\uff1aEvaluate\u5831\u544a\" class=\"lazyload c-img\" height=\"540\" loading=\"lazy\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271170%27%20height%3D%27540%27%20viewBox%3D%270%200%201170%20540%27%3E%3Crect%20width%3D%271170%27%20height%3D%27540%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/witology.com.tw\/wp-content\/uploads\/2026\/06\/featured_1-35.png\" width=\"1170\"\/>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>\u6839\u64daEvaluate\u6700\u65b0\u5831\u544a\uff0c\u5728GLP-1\u6e1b\u91cd\u85e5\u6301\u7e8c\u7206\u767c\u6027\u6210\u9577\u4ee5\u53ca\u4e2d\u570b\u91ab\u85e5\u5e02\u5834\u52a0\u901f\u5d1b\u8d77\u7684\u96d9\u91cd\u9a45\u52d5\u4e0b\uff0c\u5168\u7403\u8655\u65b9\u85e5\u92b7\u552e\u984d\u6709\u671b\u57282032\u5e74\u7a81\u78342\u5146\u7f8e\u5143\u5927\u95dc\u3002\u80a5\u80d6\u75c7\u6cbb\u7642\u9818\u57df\u5df2\u6210\u70ba\u5168\u7403\u85e5\u5ee0\u6700\u91cd\u8981\u7684\u6230\u7565\u8ced\u6ce8\uff0c\u5404\u5927\u85e5\u5ee0\u722d\u76f8\u5e03\u5c40GLP-1\u53ca\u4e0b\u4e00\u4ee3\u4ee3\u8b1d\u75be\u75c5\u7642\u6cd5\u3002\u4e2d\u570b\u4f5c\u70ba\u5168\u7403\u7b2c\u4e8c\u5927\u85e5\u54c1\u5e02\u5834\uff0c\u5176\u672c\u571f\u5275\u65b0\u85e5\u7814\u767c\u80fd\u529b\u7684\u5feb\u901f\u63d0\u5347\u6b63\u91cd\u5851\u5168\u7403\u88fd\u85e5\u7522\u696d\u683c\u5c40\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403\u85e5\u54c1\u5e02\u58342032\u5e74\u92b7\u552e\u984d\u9810\u6e2c\u90542\u5146\u7f8e\u5143\uff1bGLP-1\u5e02\u5834\uff08Wegovy\u3001Zepbound\uff092030\u5e74\u9810\u4f30\u898f\u6a21\u903e1,500\u5104\u7f8e\u5143\uff1b\u4e2d\u570b\u91ab\u85e5\u5e02\u5834\u5e74\u589e\u901f\u7d046-8%\uff0c\u9810\u8a082032\u5e74\u4f54\u5168\u7403\u5e02\u5834\u7d0420%\uff1bNovo Nordisk\u8207Eli Lilly\u5408\u8a08GLP-1\u5e02\u5834\u5e02\u4f54\u8d85\u904e85%\uff1b\u5168\u7403\u80a5\u80d6\u75c7\u60a3\u8005\u4eba\u6578\u8d85\u904e10\u5104\uff0c\u6f5b\u5728\u85e5\u7269\u53ef\u53ca\u6027\u4ecd\u4f4e\u65bc5%\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>\u5168\u7403\u85e5\u54c1\u5e02\u5834\u9081\u54112\u5146\u7f8e\u5143\u7684\u91cc\u7a0b\u7891\uff0c\u6838\u5fc3\u9a45\u52d5\u529b\u5df2\u5f9e\u50b3\u7d71\u816b\u7624\u85e5\u7269\u8f49\u79fb\u81f3\u4ee5GLP-1\u70ba\u4ee3\u8868\u7684\u4ee3\u8b1d\u75be\u75c5\u5e73\u53f0\uff0c\u9019\u662f\u8fd120\u5e74\u4f86\u6700\u91cd\u5927\u7684\u6cbb\u7642\u5178\u7bc4\u8f49\u79fb\u3002GLP-1\u7642\u6cd5\u4e0d\u50c5\u985b\u8986\u80a5\u80d6\u75c7\u6cbb\u7642\uff0c\u5176\u5fc3\u81df\u4fdd\u8b77\u3001\u814e\u81df\u4fdd\u8b77\u3001\u8102\u80aa\u809d\uff08MASH\uff09\u7b49\u9069\u61c9\u75c7\u64f4\u5f35\u6b63\u5275\u9020\u51fa\u8de8\u79d1\u5225\u7684\u8d85\u7d1a\u5e02\u5834\uff0c\u4f7f\u9f8d\u982d\u85e5\u5ee0\u4f30\u503c\u6301\u7e8c\u4e0a\u4fee\u3002\u4e2d\u570b\u88fd\u85e5\u696d\u7684\u5d1b\u8d77\u5247\u70ba\u5e02\u5834\u5e36\u4f86\u96d9\u9762\u6548\u61c9\uff1a\u4e00\u65b9\u9762\u8ca2\u737b\u5de8\u5927\u7684\u589e\u91cf\u9700\u6c42\uff0c\u53e6\u4e00\u65b9\u9762\u672c\u571f\u85e5\u5ee0\uff08\u5982\u4fe1\u9054\u3001\u767e\u6fdf\u3001\u6046\u745e\uff09\u7684\u5feb\u901f\u8ddf\u9032\u6b63\u58d3\u7e2e\u8de8\u570b\u85e5\u5ee0\u5728\u83ef\u7684\u5b9a\u50f9\u7a7a\u9593\u3002\u53f0\u7063CDMO\u8207\u539f\u6599\u85e5\u5ee0\u5546\uff08\u5982\u795e\u9686\u3001\u53f0\u8000\uff09\u6709\u6a5f\u6703\u53d7\u60e0\u65bcGLP-1\u88fd\u9020\u9700\u6c42\u5916\u6ea2\uff0c\u4f46\u9700\u53ca\u65e9\u5e03\u5c40\u591a\u80bd\u5408\u6210\u7522\u80fd\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>2\u5146\u7f8e\u5143\u7684\u9810\u6e2c\u9ad8\u5ea6\u4f9d\u8cf4GLP-1\u5e02\u5834\u6301\u7e8c\u9ad8\u901f\u6210\u9577\u8207\u4e2d\u570b\u5e02\u5834\u958b\u653e\u5047\u8a2d\uff0c\u4f46\u4e00\u65e6\u7f8e\u570bMedicare\u85e5\u50f9\u8ac7\u5224\u58d3\u4f4eGLP-1\u5b9a\u50f9\u3001\u4e2d\u570b\u672c\u571f\u4eff\u88fd\u85e5\u6216\u751f\u7269\u76f8\u4f3c\u85e5\u63d0\u524d\u5165\u5e02\uff0c\u6216\u9577\u671f\u81e8\u5e8a\u6578\u64da\u51fa\u73fe\u808c\u8089\u840e\u7e2e\u3001\u80f0\u81df\u708e\u7b49\u56b4\u91cd\u526f\u4f5c\u7528\uff0c\u5e02\u5834\u898f\u6a21\u6050\u5927\u5e45\u4f4e\u65bc\u9810\u671f\uff1b\u6b64\u5916\uff0c\u5730\u7de3\u653f\u6cbb\u98a8\u96aa\u53ef\u80fd\u4f7f\u4e2d\u570b\u5e02\u5834\u5c0d\u8de8\u570b\u85e5\u5ee0\u7684\u8ca2\u737b\u9060\u6bd4\u9810\u6e2c\u4fdd\u5b88\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Novo Nordisk\u8207Eli Lilly 2025\u5e74Q2\u8ca1\u5831\u63ed\u793aGLP-1\u5be6\u969b\u92b7\u552e\u6210\u9577\u52d5\u80fd\u8207\u7522\u80fd\u74f6\u9838<\/li><li>\u7f8e\u570bIRA\u6cd5\u6848\u5c0dGLP-1\u85e5\u54c1Medicare\u5b9a\u50f9\u8ac7\u5224\u7684\u6700\u65b0\u9032\u5c55<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>\u53e3\u670dGLP-1\uff08\u5982Lilly\u7684orforglipron\u3001Novo\u7684semaglutide\u53e3\u670d\u7248\uff09\u81e8\u5e8a\u4e09\u671f\u6578\u64da\u516c\u5e03\u6642\u7a0b<\/li><li>\u4e2d\u570b\u672c\u571fGLP-1\u85e5\u5ee0\uff08\u4fe1\u9054\u751f\u7269\u3001\u83ef\u6771\u91ab\u85e5\uff09\u5546\u696d\u5316\u9032\u5ea6\u8207\u5b9a\u50f9\u7b56\u7565<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>GLP-1\u5c08\u5229\u5230\u671f\u5f8c\u751f\u7269\u76f8\u4f3c\u85e5\u5e02\u5834\u7d50\u69cb\u91cd\u7d44\u5c0d\u9f8d\u982d\u5ee0\u5546\u5229\u6f64\u7387\u7684\u9577\u671f\u4fb5\u8755<\/li><li>\u4ee3\u8b1d\u75be\u75c5\u5e73\u53f0\u662f\u5426\u80fd\u5efa\u7acb\u5982\u540c\u816b\u7624\u514d\u75ab\u7642\u6cd5\u822c\u7684\u6a19\u6e96\u6cbb\u7642\u5730\u4f4d\uff0c\u6c7a\u5b9a\u5e02\u5834\u5929\u82b1\u677f\u9ad8\u5ea6<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u5168\u7403\u85e5\u54c1\u5e02\u5834\u771f\u7684\u80fd\u57282032\u5e74\u9054\u52302\u5146\u7f8e\u5143\u55ce\uff1f\u4e3b\u8981\u52d5\u529b\u662f\u4ec0\u9ebc\uff1f<\/summary><p>\u6839\u64daEvaluate\u5831\u544a\uff0c\u6700\u5927\u9a45\u52d5\u529b\u662fGLP-1\u6e1b\u91cd\u85e5\u5e02\u5834\u7206\u767c\uff08\u9810\u4f302030\u5e74\u7a81\u78341,500\u5104\u7f8e\u5143\uff09\u4ee5\u53ca\u4e2d\u570b\u91ab\u85e5\u5e02\u5834\u5e74\u57476-8%\u7684\u6301\u7e8c\u6210\u9577\uff0c\u5169\u8005\u5408\u8a08\u53ef\u671b\u652f\u6490\u6574\u9ad4\u5e02\u5834\u9081\u54112\u5146\u7f8e\u5143\uff0c\u4f46\u6b64\u9810\u6e2c\u9ad8\u5ea6\u4f9d\u8cf4\u653f\u7b56\u74b0\u5883\u8207\u7af6\u722d\u683c\u5c40\u7dad\u6301\u7a69\u5b9a\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u53f0\u7063\u751f\u6280\u516c\u53f8\u80fd\u5f9e\u5168\u7403\u85e5\u54c1\u5e02\u58342\u5146\u7f8e\u5143\u7684\u8da8\u52e2\u4e2d\u53d7\u60e0\u55ce\uff1f<\/summary><p>\u53f0\u7063CDMO\u8207\u539f\u6599\u85e5\u5ee0\uff08\u5982\u795e\u9686\u5316\u5b78\u3001\u53f0\u8000\u5316\u5b78\uff09\u5177\u5099\u591a\u80bd\u5408\u6210\u6280\u8853\uff0c\u6709\u6a5f\u6703\u627f\u63a5GLP-1\u985e\u85e5\u7269\u7684\u539f\u6599\u6216\u4e2d\u9593\u9ad4\u4ee3\u5de5\u9700\u6c42\uff1b\u6b64\u5916\uff0c\u9ad4\u5916\u8a3a\u65b7\u8207\u4ee3\u8b1d\u75be\u75c5\u76f8\u95dc\u91ab\u6750\u5ee0\u4e5f\u53ef\u671b\u53d7\u60e0\u65bc\u9f90\u5927\u7684\u60a3\u8005\u7be9\u6aa2\u9700\u6c42\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u4e2d\u570b\u85e5\u5ee0\u5d1b\u8d77\u5c0d\u5168\u7403\u88fd\u85e5\u5e02\u5834\u662f\u6a5f\u6703\u9084\u662f\u5a01\u8105\uff1f<\/summary><p>\u5c0d\u8de8\u570b\u85e5\u5ee0\u800c\u8a00\uff0c\u4e2d\u570b\u662f\u5de8\u5927\u7684\u589e\u91cf\u5e02\u5834\uff0c\u4f46\u672c\u571f\u85e5\u5ee0\u5feb\u901f\u8ffd\u8d95\u6b63\u58d3\u7e2e\u5728\u83ef\u5229\u6f64\u7a7a\u9593\uff1b\u5c0d\u53f0\u7063\u8207\u5176\u4ed6\u4e9e\u6d32\u5ee0\u5546\u800c\u8a00\uff0c\u4e2d\u570b\u5275\u65b0\u85e5\u7684\u6388\u6b0a\u5408\u4f5c\uff08license-out\uff09\u9700\u6c42\u589e\u52a0\uff0c\u53cd\u800c\u5275\u9020\u65b0\u7684\u5546\u696d\u6a5f\u6703\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/pharma\/big-obesity-bets-and-chinas-rise-fuel-potential-2t-2032-drug-sales-evaluate\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/merck-kgaa-pledges-50m-build-new-cardio-biotech-eye-later-acquisition\" rel=\"noopener nofollow\" target=\"_blank\">Merck KGaA\u627f\u8afe\u6295\u51655,000\u842c\u7f8e\u5143\u6276\u690d\u65b0\u5fc3\u8840\u7ba1\u751f\u6280\u516c\u53f8\uff0c\u610f\u5728\u65e5\u5f8c\u6536\u8cfc<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-06-25\" itemprop=\"datePublished\">2026-06-25<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cb\u25cb<\/span><span class=\"c-hype-tx\">3\/5 \u00b7 \u503c\u5f97\u95dc\u6ce8<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-other\"><b>MRK<\/b> Merck KGaA <span class=\"chg chg-up\">\u25b20.84% $120.6<\/span><\/span><span class=\"stk stk-us\"><b>NVO<\/b> Novo Nordisk <span class=\"chg chg-down\">\u25bc0.02% $47.41<\/span><\/span><span class=\"stk stk-us\"><b>AZN<\/b> AstraZeneca <span class=\"chg chg-up\">\u25b21.10% $183.02<\/span><\/span><span class=\"stk stk-us\"><b>BMY<\/b> Bristol-Myers Squibb <span class=\"chg chg-down\">\u25bc0.95% $55.0<\/span><\/span><span class=\"stk stk-us\"><b>NVS<\/b> Novartis <span class=\"chg chg-down\">\u25bc0.17% $153.12<\/span><\/span><span class=\"stk stk-tw\"><b>4147<\/b> \u4e2d\u88d5\u65b0\u85e5 <span class=\"chg chg-flat\">\u2014<\/span><\/span><span class=\"stk stk-tw\"><b>4726<\/b> \u6c38\u6615\u751f\u91ab <span class=\"chg chg-flat\">\u2014<\/span><\/span><span class=\"stk stk-tw\"><b>6760<\/b> \u535a\u9338\u751f\u6280 <span class=\"chg chg-flat\">\u2014<\/span><\/span><\/div>\n<img decoding=\"async\" alt=\"Merck KGaA\u627f\u8afe\u6295\u51655,000\u842c\u7f8e\u5143\u6276\u690d\u65b0\u5fc3\u8840\u7ba1\u751f\u6280\u516c\u53f8\uff0c\u610f\u5728\u65e5\u5f8c\u6536\u8cfc\" class=\"lazyload c-img\" height=\"540\" loading=\"lazy\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271170%27%20height%3D%27540%27%20viewBox%3D%270%200%201170%20540%27%3E%3Crect%20width%3D%271170%27%20height%3D%27540%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/witology.com.tw\/wp-content\/uploads\/2026\/06\/featured_2-38.png\" width=\"1170\"\/>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>\u5fb7\u570b\u88fd\u85e5\u5de8\u982dMerck KGaA\u5ba3\u5e03\u6295\u51655,000\u842c\u7f8e\u5143\uff0c\u4ee5\u300c\u5efa\u7acb\u5f8c\u6536\u8cfc\u300d\uff08build-to-buy\uff09\u6a21\u5f0f\u5b75\u5316\u4e00\u5bb6\u5c08\u6ce8\u5fc3\u8840\u7ba1\u9818\u57df\u7684\u65b0\u751f\u6280\u516c\u53f8\uff0c\u610f\u5716\u900f\u904e\u65e9\u671f\u8cc7\u672c\u4ecb\u5165\u53d6\u5f97\u512a\u5148\u6536\u8cfc\u6b0a\uff0c\u800c\u975e\u5728\u5e02\u5834\u7af6\u50f9\u6230\u4e2d\u6436\u6a19\u6210\u719f\u8cc7\u7522\u3002\u6b64\u8209\u53cd\u6620\u5927\u85e5\u5ee0\u5728\u5fc3\u8840\u7ba1\u6cbb\u7642\u9818\u57df\u7ba1\u7dda\u7a7a\u6d1e\u7684\u5371\u6a5f\u611f\uff0c\u4ee5\u53ca\u5c0d\u50b3\u7d71\u9ad8\u6ea2\u50f9\u6536\u8cfc\u7b56\u7565\u7684\u53cd\u601d\u3002Merck KGaA\u5e0c\u671b\u85c9\u6b64\u6a21\u5f0f\u5728\u5fc3\u81df\u8870\u7aed\u3001\u52d5\u8108\u7ca5\u6a23\u786c\u5316\u7b49\u9818\u57df\u5efa\u7acb\u5dee\u7570\u5316\u7ba1\u7dda\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u6295\u8cc7\u91d1\u984d\uff1a5,000\u842c\u7f8e\u5143\u7a2e\u5b50\/\u521d\u671f\u8cc7\u91d1\uff1b\u5168\u7403\u5fc3\u8840\u7ba1\u75be\u75c5\u85e5\u7269\u5e02\u5834\u898f\u6a21\u7d04650\u5104\u7f8e\u5143\uff082024\uff09\uff0c\u9810\u8a082030\u5e74\u8d85\u904e900\u5104\u7f8e\u5143\uff1b\u300cbuild-to-buy\u300d\u6a21\u5f0f\u5e73\u5747\u7bc0\u7701\u6536\u8cfc\u6ea2\u50f9\u7d0430-40%\uff08\u76f8\u8f03\u516c\u958b\u5e02\u5834\u7af6\u8cfc\uff09\uff1bMerck KGaA 2024\u5e74\u7814\u767c\u652f\u51fa\u7d0429\u5104\u6b50\u5143\uff0c\u5fc3\u8840\u7ba1\u70ba\u65b0\u8208\u7b56\u7565\u91cd\u9ede\u9818\u57df\u4e4b\u4e00\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Merck KGaA\u63a1\u7528\u300cbuild-to-buy\u300d\u6a21\u5f0f\u9032\u8ecd\u5fc3\u8840\u7ba1\u9818\u57df\uff0c\u4ee3\u8868\u5927\u578b\u88fd\u85e5\u516c\u53f8\u6b63\u5728\u7cfb\u7d71\u6027\u91cd\u65b0\u8a2d\u8a08\u5916\u90e8\u5275\u65b0\u7372\u53d6\u7b56\u7565\uff0c\u4ee5\u898f\u907f\u50b3\u7d71M&amp;A\u7af6\u50f9\u6230\u7684\u9ad8\u6ea2\u50f9\u98a8\u96aa\u3002\u5fc3\u8840\u7ba1\u6cbb\u7642\u56e0GLP-1\u85e5\u7269\u5c55\u793a\u5fc3\u81df\u4fdd\u8b77\u6548\u76ca\u800c\u91cd\u71c3\u6295\u8cc7\u71b1\u60c5\uff0c\u5404\u5927\u85e5\u5ee0\u610f\u8b58\u5230\u82e5\u4e0d\u63d0\u65e9\u5e03\u5c40\uff0c\u672a\u4f86\u5c07\u9762\u81e8\u7ba1\u7dda\u771f\u7a7a\u3002\u6b64\u6a21\u5f0f\u5c0d\u751f\u6280\u65b0\u5275\u800c\u8a00\u662f\u4e00\u628a\u96d9\u5203\u528d\uff1a\u96d6\u80fd\u7372\u5f97\u78ba\u5b9a\u6027\u8cc7\u91d1\uff0c\u4f46\u65e9\u671f\u7d81\u5b9a\u55ae\u4e00\u6230\u7565\u8cb7\u5bb6\u53ef\u80fd\u58d3\u7e2e\u672a\u4f86\u4f30\u503c\u8ac7\u5224\u7a7a\u9593\u3002\u5c0d\u53f0\u7063\u5fc3\u8840\u7ba1\u76f8\u95dc\u751f\u6280\u5ee0\u5546\uff0c\u6b64\u985e\u5b75\u5316\u8cc7\u91d1\u6a21\u5f0f\u503c\u5f97\u501f\u9451\uff0c\u6709\u6a5f\u6703\u6210\u70ba\u570b\u969b\u85e5\u5ee0\u300c\u5efa\u7acb\u5f8c\u6536\u8cfc\u300d\u7b56\u7565\u7684\u4e9e\u592a\u6280\u8853\u5408\u4f5c\u5c0d\u8c61\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>5,000\u842c\u7f8e\u5143\u5c0d\u65bc\u5fc3\u8840\u7ba1\u85e5\u7269\u958b\u767c\u800c\u8a00\u8cc7\u91d1\u898f\u6a21\u504f\u5c0f\uff0c\u5f9e\u6982\u5ff5\u9a57\u8b49\u5230Phase II\u5b8c\u6210\u901a\u5e38\u9700\u89811.5-3\u5104\u7f8e\u5143\uff0c\u5f8c\u7e8c\u662f\u5426\u80fd\u843d\u5be6\u6536\u8cfc\u627f\u8afe\u9ad8\u5ea6\u4f9d\u8cf4\u65e9\u671f\u81e8\u5e8a\u6578\u64da\u8868\u73fe\uff1b\u6b64\u5916\uff0cMerck KGaA\u5728\u816b\u7624\u8207\u795e\u7d93\u79d1\u5b78\u7684\u8cc7\u6e90\u5206\u914d\u512a\u5148\u5ea6\u660e\u986f\u9ad8\u65bc\u5fc3\u8840\u7ba1\uff0c\u6b64\u8209\u66f4\u50cf\u662f\u7b56\u7565\u6027\u300c\u4f54\u4f4d\u300d\u800c\u975e\u9577\u671f\u6df1\u5ea6\u627f\u8afe\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>\u65b0\u5fc3\u8840\u7ba1\u751f\u6280\u516c\u53f8\u7684\u6b63\u5f0f\u63ed\u724c\u3001\u7ba1\u7406\u5718\u968a\u7d44\u6210\u8207\u6280\u8853\u5e73\u53f0\u65b9\u5411\u516c\u5e03<\/li><li>Merck KGaA\u57282025\u5e74\u4e0b\u534a\u5e74\u6cd5\u8aaa\u6703\u4e2d\u8aaa\u660e\u5fc3\u8840\u7ba1\u6230\u7565\u5e03\u5c40\u7d30\u7bc0<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>\u8a72\u65b0\u5275\u516c\u53f8\u9996\u500b\u5019\u9078\u85e5\u7269\u9032\u5165IND\u7533\u8acb\u6216Phase I\u8a66\u9a57\u7684\u6642\u7a0b<\/li><li>\u7af6\u722d\u5c0d\u624b\uff08AstraZeneca\u3001Novartis\uff09\u662f\u5426\u8ddf\u9032\u985e\u4f3c\u300cbuild-to-buy\u300d\u5b75\u5316\u6a21\u5f0f<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>Merck KGaA\u662f\u5426\u5982\u671f\u884c\u4f7f\u6536\u8cfc\u9078\u64c7\u6b0a\uff0c\u4ee5\u53ca\u6700\u7d42\u6536\u8cfc\u4f30\u503c\u662f\u5426\u9a57\u8b49\u6b64\u6a21\u5f0f\u7684\u6210\u672c\u6548\u76ca<\/li><li>\u5fc3\u8840\u7ba1\u9818\u57df\u300cbuild-to-buy\u300d\u6a21\u5f0f\u80fd\u5426\u6210\u70ba\u7522\u696d\u6a19\u6e96\uff0c\u53d6\u4ee3\u90e8\u5206\u50b3\u7d71\u6388\u6b0a\u5f15\u9032\uff08licensing-in\uff09\u4ea4\u6613<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u300cbuild-to-buy\u300d\u662f\u4ec0\u9ebc\u610f\u601d\uff1f\u548c\u4e00\u822c\u6536\u8cfc\u6709\u4ec0\u9ebc\u4e0d\u540c\uff1f<\/summary><p>\u300cbuild-to-buy\u300d\u662f\u6307\u5927\u85e5\u5ee0\u9810\u5148\u6295\u5165\u8cc7\u91d1\u5e6b\u52a9\u65b0\u516c\u53f8\u5f9e\u96f6\u5efa\u7acb\uff0c\u540c\u6642\u53d6\u5f97\u672a\u4f86\u512a\u5148\u6536\u8cfc\u6b0a\uff1b\u76f8\u8f03\u65bc\u7b49\u5f85\u516c\u53f8\u6210\u719f\u5f8c\u5728\u516c\u958b\u5e02\u5834\u7af6\u8cfc\uff0c\u6b64\u6a21\u5f0f\u53ef\u7bc0\u770130-40%\u7684\u6536\u8cfc\u6ea2\u50f9\uff0c\u4e26\u8b93\u5927\u85e5\u5ee0\u66f4\u65e9\u4ecb\u5165\u6280\u8853\u65b9\u5411\u8a2d\u5b9a\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>Merck KGaA\u70ba\u4ec0\u9ebc\u9078\u5728\u9019\u500b\u6642\u9593\u9ede\u62bc\u6ce8\u5fc3\u8840\u7ba1\u9818\u57df\uff1f<\/summary><p>GLP-1\u6e1b\u91cd\u85e5\uff08\u5982Wegovy\u3001Zepbound\uff09\u5df2\u81e8\u5e8a\u8b49\u5be6\u5177\u5099\u5fc3\u81df\u4fdd\u8b77\u6548\u76ca\uff0c\u91cd\u65b0\u9ede\u71c3\u5e02\u5834\u5c0d\u5fc3\u8840\u7ba1\u6cbb\u7642\u7684\u6295\u8cc7\u71b1\u60c5\uff1b\u52a0\u4e0aMerck KGaA\u73fe\u6709\u5fc3\u8840\u7ba1\u7ba1\u7dda\u76f8\u5c0d\u8584\u5f31\uff0c\u63d0\u65e9\u5e03\u5c40\u53ef\u907f\u514d\u672a\u4f86\u5728\u7af6\u8cfc\u6230\u4e2d\u652f\u4ed8\u9ad8\u6ea2\u50f9\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u7b465,000\u842c\u7f8e\u5143\u7684\u6295\u8cc7\u5c0d\u65b0\u5275\u516c\u53f8\u5920\u7528\u55ce\uff1f<\/summary><p>\u5fc3\u8840\u7ba1\u85e5\u7269\u5f9e\u65e9\u671f\u7814\u767c\u5230\u5b8c\u6210Phase II\u8a66\u9a57\u901a\u5e38\u9700\u89811.5\u81f33\u5104\u7f8e\u5143\uff0c5,000\u842c\u7f8e\u5143\u50c5\u8db3\u4ee5\u652f\u6490\u6982\u5ff5\u9a57\u8b49\u8207\u65e9\u671f\u81e8\u5e8a\u524d\u968e\u6bb5\uff0c\u5f8c\u7e8c\u4ecd\u9700\u8ffd\u52a0\u878d\u8cc7\u6216Merck KGaA\u9032\u4e00\u6b65\u6ce8\u8cc7\u624d\u80fd\u63a8\u9032\u81e8\u5e8a\u8a66\u9a57\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/merck-kgaa-pledges-50m-build-new-cardio-biotech-eye-later-acquisition\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<\/section>\n<section aria-labelledby=\"sec-briefs\">\n<h2 class=\"lbl\" id=\"sec-briefs\">\u4eca\u65e5\u5feb\u8a0a<\/h2>\n<ul class=\"briefs\" style=\"list-style:none\">\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/discreet-biotech-osanni-bio-starts-making-noise-190m-series-b-clinical-push\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/biotech\/discreet-biotech-osanni-bio-starts-making-noise-190m-series-b-clinical-push&#8221; hreflang=&#8221;en&#8221;&gt;Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/eli-lilly-reunites-abbisko-19b-multitarget-rd-pact\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/biotech\/eli-lilly-reunites-abbisko-19b-multitarget-rd-pact&#8221; hreflang=&#8221;en&#8221;&gt;Eli Lilly reunites with Abbisko in $1.9B, multiple target R&amp;amp;D pact&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/novartis-pays-antares-105m-illuminate-undruggable-cancer-targets\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/biotech\/novartis-pays-antares-105m-illuminate-undruggable-cancer-targets&#8221; hreflang=&#8221;en&#8221;&gt;Novartis pays Antares $105M to illuminate undruggable cancer targets&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#FFC000\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/pharma\/nature-retracts-provocative-pd-1-study-tied-lung-cancer-survival-treatment-timing\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/pharma\/nature-retracts-provocative-pd-1-study-tied-lung-cancer-survival-treatment-timing&#8221; hreflang=&#8221;en&#8221;&gt;Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u751f\u547d\u79d1\u5b78 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/mapp-gilead-antivirals-be-deployed-drc-ebola-trial-who-chief\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/biotech\/mapp-gilead-antivirals-be-deployed-drc-ebola-trial-who-chief&#8221; hreflang=&#8221;en&#8221;&gt;Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#70AD47\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/spurned-fda-passage-bio-finds-exit-through-merger-remix\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/biotech\/spurned-fda-passage-bio-finds-exit-through-merger-remix&#8221; hreflang=&#8221;en&#8221;&gt;Spurned by FDA, Passage Bio finds exit through merger with Remix&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u65b0\u8208\u7642\u6cd5 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<\/ul>\n<\/section>\n<section aria-labelledby=\"sec-stats\" class=\"stats\" style=\"margin-top:48px\">\n<h2 class=\"lbl\" id=\"sec-stats\" style=\"font-size:16px;border-bottom-width:1px\">\u5206\u985e\u7d71\u8a08<\/h2>\n<div class=\"st\"><div class=\"st-bar\" style=\"width:75.0%;background:#4472C4\"><\/div><span class=\"st-lb\">\u85e5\u7269<\/span><span class=\"st-ct\">6<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:12.5%;background:#70AD47\"><\/div><span class=\"st-lb\">\u65b0\u8208\u7642\u6cd5<\/span><span class=\"st-ct\">1<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:12.5%;background:#FFC000\"><\/div><span class=\"st-lb\">\u751f\u547d\u79d1\u5b78<\/span><span class=\"st-ct\">1<\/span><\/div>\n<\/section>\n<!-- footer \u5df2\u79fb\u9664(v2.14.0) -->\n<\/main>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2026 \u5e74 06 \u6708 25 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 \u5171\u6536\u9304 8 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 2 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790 \u7cbe\u9078 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":7356,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"rank_math_title":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-06-25\uff5c\u80a5\u80d6\u75c7\u5927\u8ced\u6ce8\u8207\u4e2d\u570b\u5d1b\u8d77\u63a8\u52d52032\u5e74\u5168\u7403\u85e5\u54c1\u92b7\u552e\u984d\u6709","rank_math_description":"2026 \u5e74 06 \u6708 25 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1a\u80a5\u80d6\u75c7\u5927\u8ced\u6ce8\u8207\u4e2d\u570b\u5d1b\u8d77\u63a8\u52d52032\u5e74\u5168\u7403\u85e5\u54c1\u92b7\u552e\u984d\u6709\u671b\u90542\u5146\u7f8e\u5143\uff1aEv\u3001Merck KGaA\u627f\u8afe\u6295\u51655,000\u842c\u7f8e\u5143\u6276\u690d\u65b0\u5fc3\u8840\u7ba1\u751f\u6280\u516c\u53f8\uff0c\u610f\u5728\u3002\u5171\u6536\u9304 8 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002","rank_math_focus_keyword":"\u751f\u91ab\u5927\u5065\u5eb7","rank_math_robots":"","daily_schema_jsonld":"[\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"CollectionPage\",\n    \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-06-25\uff5c\u80a5\u80d6\u75c7\u5927\u8ced\u6ce8\u8207\u4e2d\u570b\u5d1b\u8d77\u63a8\u52d52032\u5e74\u5168\u7403\u85e5\u54c1\u92b7\u552e\u984d\u6709\",\n    \"description\": \"2026 \u5e74 06 \u6708 25 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1a\u80a5\u80d6\u75c7\u5927\u8ced\u6ce8\u8207\u4e2d\u570b\u5d1b\u8d77\u63a8\u52d52032\u5e74\u5168\u7403\u85e5\u54c1\u92b7\u552e\u984d\u6709\u671b\u90542\u5146\u7f8e\u5143\uff1aEv\u3001Merck KGaA\u627f\u8afe\u6295\u51655,000\u842c\u7f8e\u5143\u6276\u690d\u65b0\u5fc3\u8840\u7ba1\u751f\u6280\u516c\u53f8\uff0c\u610f\u5728\u3002\u5171\u6536\u9304 8 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002\",\n    \"url\": \"https:\/\/witology.com.tw\/daily\/2026-06-25\",\n    \"datePublished\": \"2026-06-25\",\n    \"inLanguage\": \"zh-TW\",\n    \"publisher\": {\n      \"@type\": \"Organization\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n      }\n    },\n    \"isPartOf\": {\n      \"@type\": \"WebSite\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"url\": \"https:\/\/witology.com.tw\"\n    },\n    \"hasPart\": [\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"\u80a5\u80d6\u75c7\u5927\u8ced\u6ce8\u8207\u4e2d\u570b\u5d1b\u8d77\u63a8\u52d52032\u5e74\u5168\u7403\u85e5\u54c1\u92b7\u552e\u984d\u6709\u671b\u90542\u5146\u7f8e\u5143\uff1aEvaluate\u5831\u544a\",\n        \"datePublished\": \"2026-06-25\",\n        \"dateModified\": \"2026-06-25\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/daily\/2026-06-25\/featured_1.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-06-25#article-1\"\n        },\n        \"description\": \"\u6839\u64daEvaluate\u6700\u65b0\u5831\u544a\uff0c\u5728GLP-1\u6e1b\u91cd\u85e5\u6301\u7e8c\u7206\u767c\u6027\u6210\u9577\u4ee5\u53ca\u4e2d\u570b\u91ab\u85e5\u5e02\u5834\u52a0\u901f\u5d1b\u8d77\u7684\u96d9\u91cd\u9a45\u52d5\u4e0b\uff0c\u5168\u7403\u8655\u65b9\u85e5\u92b7\u552e\u984d\u6709\u671b\u57282032\u5e74\u7a81\u78342\u5146\u7f8e\u5143\u5927\u95dc\u3002\u80a5\u80d6\u75c7\u6cbb\u7642\u9818\u57df\u5df2\u6210\u70ba\u5168\u7403\u85e5\u5ee0\u6700\u91cd\u8981\u7684\u6230\u7565\u8ced\u6ce8\uff0c\u5404\u5927\u85e5\u5ee0\u722d\u76f8\u5e03\u5c40GLP-1\u53ca\u4e0b\u4e00\u4ee3\u4ee3\u8b1d\u75be\u75c5\u7642\u6cd5\u3002\u4e2d\u570b\u4f5c\u70ba\u5168\u7403\u7b2c\u4e8c\u5927\u85e5\u54c1\u5e02\u5834\uff0c\u5176\u672c\u571f\u5275\u65b0\u85e5\u7814\u767c\u80fd\u529b\u7684\u5feb\u901f\u63d0\u5347\u6b63\u91cd\u5851\u5168\u7403\u88fd\u85e5\u7522\u696d\u683c\u5c40\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-06-25#article-1\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/pharma\/big-obesity-bets-and-chinas-rise-fuel-potential-2t-2032-drug-sales-evaluate\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Novo Nordisk\",\n            \"tickerSymbol\": \"NVO\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Eli Lilly\",\n            \"tickerSymbol\": \"LLY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"AstraZeneca\",\n            \"tickerSymbol\": \"AZN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Pfizer\",\n            \"tickerSymbol\": \"PFE\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Roche\",\n            \"tickerSymbol\": \"ROG\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u4e2d\u570b\u751f\u7269\u88fd\u85e5\",\n            \"tickerSymbol\": \"1177\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u4fe1\u9054\u751f\u7269\",\n            \"tickerSymbol\": \"1801\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u85e5\u83ef\u85e5\",\n            \"tickerSymbol\": \"6446\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u667a\u64ce\u751f\u6280\",\n            \"tickerSymbol\": \"4162\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Merck KGaA\u627f\u8afe\u6295\u51655,000\u842c\u7f8e\u5143\u6276\u690d\u65b0\u5fc3\u8840\u7ba1\u751f\u6280\u516c\u53f8\uff0c\u610f\u5728\u65e5\u5f8c\u6536\u8cfc\",\n        \"datePublished\": \"2026-06-25\",\n        \"dateModified\": \"2026-06-25\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/daily\/2026-06-25\/featured_2.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-06-25#article-2\"\n        },\n        \"description\": \"\u5fb7\u570b\u88fd\u85e5\u5de8\u982dMerck KGaA\u5ba3\u5e03\u6295\u51655,000\u842c\u7f8e\u5143\uff0c\u4ee5\u300c\u5efa\u7acb\u5f8c\u6536\u8cfc\u300d\uff08build-to-buy\uff09\u6a21\u5f0f\u5b75\u5316\u4e00\u5bb6\u5c08\u6ce8\u5fc3\u8840\u7ba1\u9818\u57df\u7684\u65b0\u751f\u6280\u516c\u53f8\uff0c\u610f\u5716\u900f\u904e\u65e9\u671f\u8cc7\u672c\u4ecb\u5165\u53d6\u5f97\u512a\u5148\u6536\u8cfc\u6b0a\uff0c\u800c\u975e\u5728\u5e02\u5834\u7af6\u50f9\u6230\u4e2d\u6436\u6a19\u6210\u719f\u8cc7\u7522\u3002\u6b64\u8209\u53cd\u6620\u5927\u85e5\u5ee0\u5728\u5fc3\u8840\u7ba1\u6cbb\u7642\u9818\u57df\u7ba1\u7dda\u7a7a\u6d1e\u7684\u5371\u6a5f\u611f\uff0c\u4ee5\u53ca\u5c0d\u50b3\u7d71\u9ad8\u6ea2\u50f9\u6536\u8cfc\u7b56\u7565\u7684\u53cd\u601d\u3002Merck KGaA\u5e0c\u671b\u85c9\u6b64\u6a21\u5f0f\u5728\u5fc3\u81df\u8870\u7aed\u3001\u52d5\u8108\u7ca5\u6a23\u786c\u5316\u7b49\u9818\u57df\u5efa\u7acb\u5dee\u7570\u5316\u7ba1\u7dda\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-06-25#article-2\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/merck-kgaa-pledges-50m-build-new-cardio-biotech-eye-later-acquisition\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Merck KGaA\",\n            \"tickerSymbol\": \"MRK\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Novo Nordisk\",\n            \"tickerSymbol\": \"NVO\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"AstraZeneca\",\n            \"tickerSymbol\": \"AZN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Bristol-Myers Squibb\",\n            \"tickerSymbol\": \"BMY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Novartis\",\n            \"tickerSymbol\": \"NVS\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u4e2d\u88d5\u65b0\u85e5\",\n            \"tickerSymbol\": \"4147\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u6c38\u6615\u751f\u91ab\",\n            \"tickerSymbol\": \"4726\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u535a\u9338\u751f\u6280\",\n            \"tickerSymbol\": \"6760\"\n          }\n        ]\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"BreadcrumbList\",\n    \"itemListElement\": [\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 1,\n        \"name\": \"\u9996\u9801\",\n        \"item\": \"https:\/\/witology.com.tw\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 2,\n        \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 3,\n        \"name\": \"2026-06-25\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\/2026-06-25\"\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"FAQPage\",\n    \"mainEntity\": [\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u5168\u7403\u85e5\u54c1\u5e02\u5834\u771f\u7684\u80fd\u57282032\u5e74\u9054\u52302\u5146\u7f8e\u5143\u55ce\uff1f\u4e3b\u8981\u52d5\u529b\u662f\u4ec0\u9ebc\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u6839\u64daEvaluate\u5831\u544a\uff0c\u6700\u5927\u9a45\u52d5\u529b\u662fGLP-1\u6e1b\u91cd\u85e5\u5e02\u5834\u7206\u767c\uff08\u9810\u4f302030\u5e74\u7a81\u78341,500\u5104\u7f8e\u5143\uff09\u4ee5\u53ca\u4e2d\u570b\u91ab\u85e5\u5e02\u5834\u5e74\u57476-8%\u7684\u6301\u7e8c\u6210\u9577\uff0c\u5169\u8005\u5408\u8a08\u53ef\u671b\u652f\u6490\u6574\u9ad4\u5e02\u5834\u9081\u54112\u5146\u7f8e\u5143\uff0c\u4f46\u6b64\u9810\u6e2c\u9ad8\u5ea6\u4f9d\u8cf4\u653f\u7b56\u74b0\u5883\u8207\u7af6\u722d\u683c\u5c40\u7dad\u6301\u7a69\u5b9a\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u53f0\u7063\u751f\u6280\u516c\u53f8\u80fd\u5f9e\u5168\u7403\u85e5\u54c1\u5e02\u58342\u5146\u7f8e\u5143\u7684\u8da8\u52e2\u4e2d\u53d7\u60e0\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53f0\u7063CDMO\u8207\u539f\u6599\u85e5\u5ee0\uff08\u5982\u795e\u9686\u5316\u5b78\u3001\u53f0\u8000\u5316\u5b78\uff09\u5177\u5099\u591a\u80bd\u5408\u6210\u6280\u8853\uff0c\u6709\u6a5f\u6703\u627f\u63a5GLP-1\u985e\u85e5\u7269\u7684\u539f\u6599\u6216\u4e2d\u9593\u9ad4\u4ee3\u5de5\u9700\u6c42\uff1b\u6b64\u5916\uff0c\u9ad4\u5916\u8a3a\u65b7\u8207\u4ee3\u8b1d\u75be\u75c5\u76f8\u95dc\u91ab\u6750\u5ee0\u4e5f\u53ef\u671b\u53d7\u60e0\u65bc\u9f90\u5927\u7684\u60a3\u8005\u7be9\u6aa2\u9700\u6c42\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u4e2d\u570b\u85e5\u5ee0\u5d1b\u8d77\u5c0d\u5168\u7403\u88fd\u85e5\u5e02\u5834\u662f\u6a5f\u6703\u9084\u662f\u5a01\u8105\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u5c0d\u8de8\u570b\u85e5\u5ee0\u800c\u8a00\uff0c\u4e2d\u570b\u662f\u5de8\u5927\u7684\u589e\u91cf\u5e02\u5834\uff0c\u4f46\u672c\u571f\u85e5\u5ee0\u5feb\u901f\u8ffd\u8d95\u6b63\u58d3\u7e2e\u5728\u83ef\u5229\u6f64\u7a7a\u9593\uff1b\u5c0d\u53f0\u7063\u8207\u5176\u4ed6\u4e9e\u6d32\u5ee0\u5546\u800c\u8a00\uff0c\u4e2d\u570b\u5275\u65b0\u85e5\u7684\u6388\u6b0a\u5408\u4f5c\uff08license-out\uff09\u9700\u6c42\u589e\u52a0\uff0c\u53cd\u800c\u5275\u9020\u65b0\u7684\u5546\u696d\u6a5f\u6703\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u300cbuild-to-buy\u300d\u662f\u4ec0\u9ebc\u610f\u601d\uff1f\u548c\u4e00\u822c\u6536\u8cfc\u6709\u4ec0\u9ebc\u4e0d\u540c\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u300cbuild-to-buy\u300d\u662f\u6307\u5927\u85e5\u5ee0\u9810\u5148\u6295\u5165\u8cc7\u91d1\u5e6b\u52a9\u65b0\u516c\u53f8\u5f9e\u96f6\u5efa\u7acb\uff0c\u540c\u6642\u53d6\u5f97\u672a\u4f86\u512a\u5148\u6536\u8cfc\u6b0a\uff1b\u76f8\u8f03\u65bc\u7b49\u5f85\u516c\u53f8\u6210\u719f\u5f8c\u5728\u516c\u958b\u5e02\u5834\u7af6\u8cfc\uff0c\u6b64\u6a21\u5f0f\u53ef\u7bc0\u770130-40%\u7684\u6536\u8cfc\u6ea2\u50f9\uff0c\u4e26\u8b93\u5927\u85e5\u5ee0\u66f4\u65e9\u4ecb\u5165\u6280\u8853\u65b9\u5411\u8a2d\u5b9a\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Merck KGaA\u70ba\u4ec0\u9ebc\u9078\u5728\u9019\u500b\u6642\u9593\u9ede\u62bc\u6ce8\u5fc3\u8840\u7ba1\u9818\u57df\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"GLP-1\u6e1b\u91cd\u85e5\uff08\u5982Wegovy\u3001Zepbound\uff09\u5df2\u81e8\u5e8a\u8b49\u5be6\u5177\u5099\u5fc3\u81df\u4fdd\u8b77\u6548\u76ca\uff0c\u91cd\u65b0\u9ede\u71c3\u5e02\u5834\u5c0d\u5fc3\u8840\u7ba1\u6cbb\u7642\u7684\u6295\u8cc7\u71b1\u60c5\uff1b\u52a0\u4e0aMerck KGaA\u73fe\u6709\u5fc3\u8840\u7ba1\u7ba1\u7dda\u76f8\u5c0d\u8584\u5f31\uff0c\u63d0\u65e9\u5e03\u5c40\u53ef\u907f\u514d\u672a\u4f86\u5728\u7af6\u8cfc\u6230\u4e2d\u652f\u4ed8\u9ad8\u6ea2\u50f9\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u7b465,000\u842c\u7f8e\u5143\u7684\u6295\u8cc7\u5c0d\u65b0\u5275\u516c\u53f8\u5920\u7528\u55ce\uff1f\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u5fc3\u8840\u7ba1\u85e5\u7269\u5f9e\u65e9\u671f\u7814\u767c\u5230\u5b8c\u6210Phase II\u8a66\u9a57\u901a\u5e38\u9700\u89811.5\u81f33\u5104\u7f8e\u5143\uff0c5,000\u842c\u7f8e\u5143\u50c5\u8db3\u4ee5\u652f\u6490\u6982\u5ff5\u9a57\u8b49\u8207\u65e9\u671f\u81e8\u5e8a\u524d\u968e\u6bb5\uff0c\u5f8c\u7e8c\u4ecd\u9700\u8ffd\u52a0\u878d\u8cc7\u6216Merck KGaA\u9032\u4e00\u6b65\u6ce8\u8cc7\u624d\u80fd\u63a8\u9032\u81e8\u5e8a\u8a66\u9a57\u3002\"\n        }\n      }\n    ]\n  }\n]","daily_standalone_url":"","footnotes":""},"class_list":["post-8048","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/8048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/comments?post=8048"}],"version-history":[{"count":0,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/8048\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7356"}],"wp:attachment":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/media?parent=8048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}